Alto Neuroscience ANRO
NYSE ANRO
$28.60 +0.80 (+2.88%)
At close: Nov 10, 2026 · 4:00 PM EST

Alto Neuroscience (ANRO) Liabilities and Shareholders Equity (2022 - 2026)

Updated

Analysis

Alto Neuroscience (ANRO) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Alto Neuroscience 1.14 Bn 139.96 Mn - 326.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 326.51 Mn
Jun 30, 2026 254.07 Mn
Mar 31, 2026 276.26 Mn
Dec 31, 2025 184.69 Mn
Sep 30, 2025 147.01 Mn
Jun 30, 2025 157.88 Mn
Mar 31, 2025 171.92 Mn
Dec 31, 2024 177.54 Mn
Sep 30, 2024 191.61 Mn
Jun 30, 2024 197.36 Mn
Mar 31, 2024 209.92 Mn
Dec 31, 2023 86.63 Mn
Dec 31, 2022 50.85 Mn
API Access

Alto Neuroscience Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANRO&period=max&api_key=YOUR_API_KEY